LISA LEDOUX: Open Payments
NPI 1871171439 · PALM BAY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,483 in 101 payments from 13 companies in 2025. Trend: 2023 $2,163 · 2024 $1,884 · 2025 $2,483
Food & beverage: $2,371Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $470 |
| ABBVIE INC. | 18 | $377 |
| Teva Pharmaceuticals USA, Inc. | 11 | $372 |
| Vanda Pharmaceuticals Inc. | 14 | $236 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $202 |
| E.R. Squibb & Sons, L.L.C. | 3 | $170 |
| Alkermes, Inc. | 6 | $151 |
| Otsuka America Pharmaceutical, Inc. | 7 | $137 |
| Neurocrine BioSciences, Inc. | 5 | $128 |
| Lundbeck LLC | 4 | $97 |
Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, FANAPT, REXULTI, TRINTELLIX, COBENFY, ARISTADA.
Industry payments across FL — which companies pay providers there.
